![Viktor Roschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Viktor Roschke
Hoofd Techniek/Wetenschap/O&O bij
D&D PHARMATECH INC.
Vermogen: 27 M $ op 30-06-2026
Profiel
Viktor Roschke is the founder of Neuraly, Inc. since 2016, holding the title of Director & Chief Scientific Officer.
Current jobs include Secretary & Director at Theraly Fibrosis, Inc. and Chief Scientific Officer at D&D Pharmatech Co., Ltd. Former jobs include Executive Director-Cell Biology at Human Genome Sciences, Inc. from 2005, VP-Biopharmaceutical Research & Assay Development at Zyngenia, Inc., and Chief Operating Officer at Teva Biopharmaceuticals USA, Inc. Education includes a doctorate from Novosibirsk State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2025 | 482.036 ( 1,09% ) | 27 M $ | 30-06-2026 |
Actieve functies van Viktor Roschke
| Bedrijven | Functie | Begin |
|---|---|---|
| D&D PHARMATECH INC. | Hoofd Techniek/Wetenschap/O&O | - |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur/Bestuurslid | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Oprichter | 01-01-2016 |
Eerdere bekende functies van Viktor Roschke
| Bedrijven | Functie | Einde |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01-01-2005 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Operationeel Directeur | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Viktor Roschke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Novosibirsk State University
 Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
